Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Mellor

Showing results (121-130 of 229) with videos related to

Pageof 23
Sort By:
Toxicological Research|July 27, 2017
<i>In Silico</i> Prediction of Organ Level Toxicity: Linking Chemistry to Adverse EffectsMark T D Cronin, Steven J Enoch, Claire L Mellor, et al.
Infection and Immunity|April 23, 2008
Deficiency of indoleamine 2,3-dioxygenase enhances commensal-induced antibody responses and protects against Citrobacter rodentium-induced colitisLynne Harrington, Chittur V Srikanth, Reuben Antony, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 29, 2009
IDO activates regulatory T cells and blocks their conversion into Th17-like T cellsBabak Baban, Phillip R Chandler, Madhav D Sharma, et al.
Clinical Otolaryngology : Official Journal of ENT-UK ; Official Journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery|May 30, 2021
The immunotherapeutic role of indoleamine 2,3-dioxygenase in head and neck squamous cell carcinoma: A systematic reviewDaniel J Lin, James C K Ng, Lei Huang, et al.
Journal for Immunotherapy of Cancer|August 28, 2020
Overcoming resistance to STING agonist therapy to incite durable protective antitumor immunityHenrique Lemos, Rong Ou, Caroline McCardle, et al.
Cancer Letters|July 30, 2019
Adoptive CD8<sup>+</sup> T cell therapy against cancer:Challenges and opportunitiesXiaotao Jiang, Jiang Xu, Mingfeng Liu, et al.
Immunity|November 14, 1997
A requirement for the Rho-family GTP exchange factor Vav in positive and negative selection of thymocytesM Turner, P J Mee, A E Walters, et al.
The Prostate|January 15, 1998
Inhibins, activins, and follistatins: expression of mRNAs and cellular localization in tissues from men with benign prostatic hyperplasiaT Z Thomas, S M Chapman, W Hong, et al.
Molecular and Cellular Endocrinology|July 14, 2004
Cell-specific expression of betaC-activin in the rat reproductive tract, adrenal and liverElspeth J Gold, Moira K O'Bryan, Sally L Mellor, et al.
International Immunology|October 1, 1994
Tolerance induction by elimination of subsets of self-reactive thymocytesA M Sponaas, P D Tomlinson, R Schulz, et al.
Pageof 23

Showing results (121-130 of 229) with videos related to

Sort By:
Pageof 23
Toxicological Research|July 27, 2017
<i>In Silico</i> Prediction of Organ Level Toxicity: Linking Chemistry to Adverse EffectsMark T D Cronin, Steven J Enoch, Claire L Mellor, et al.
Infection and Immunity|April 23, 2008
Deficiency of indoleamine 2,3-dioxygenase enhances commensal-induced antibody responses and protects against Citrobacter rodentium-induced colitisLynne Harrington, Chittur V Srikanth, Reuben Antony, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 29, 2009
IDO activates regulatory T cells and blocks their conversion into Th17-like T cellsBabak Baban, Phillip R Chandler, Madhav D Sharma, et al.
Clinical Otolaryngology : Official Journal of ENT-UK ; Official Journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery|May 30, 2021
The immunotherapeutic role of indoleamine 2,3-dioxygenase in head and neck squamous cell carcinoma: A systematic reviewDaniel J Lin, James C K Ng, Lei Huang, et al.
Journal for Immunotherapy of Cancer|August 28, 2020
Overcoming resistance to STING agonist therapy to incite durable protective antitumor immunityHenrique Lemos, Rong Ou, Caroline McCardle, et al.
Cancer Letters|July 30, 2019
Adoptive CD8<sup>+</sup> T cell therapy against cancer:Challenges and opportunitiesXiaotao Jiang, Jiang Xu, Mingfeng Liu, et al.
Immunity|November 14, 1997
A requirement for the Rho-family GTP exchange factor Vav in positive and negative selection of thymocytesM Turner, P J Mee, A E Walters, et al.
The Prostate|January 15, 1998
Inhibins, activins, and follistatins: expression of mRNAs and cellular localization in tissues from men with benign prostatic hyperplasiaT Z Thomas, S M Chapman, W Hong, et al.
Molecular and Cellular Endocrinology|July 14, 2004
Cell-specific expression of betaC-activin in the rat reproductive tract, adrenal and liverElspeth J Gold, Moira K O'Bryan, Sally L Mellor, et al.
International Immunology|October 1, 1994
Tolerance induction by elimination of subsets of self-reactive thymocytesA M Sponaas, P D Tomlinson, R Schulz, et al.
Pageof 23